Mark McClung
Net worth: 62 828 $ as of 2024-05-30
Career history of Mark McClung
Former positions of Mark McClung
| Companies | Position | Start | End |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Operating Officer | 2021-10-31 | 2024-01-01 |
| Corporate Officer/Principal | 2020-04-16 | 2021-10-31 | |
| AMGEN INC. | Corporate Officer/Principal | 2014-12-31 | 2018-12-31 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Training of Mark McClung
| University of Guelph | Undergraduate Degree |
| York University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Canada | 3 |
Operational
| Undergraduate Degree | 3 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Stock Market
- Insiders
- Mark McClung
- Experience
